Clinical trial No longer in our active list Observational Ages 18 and up

Impact of Microbiome Changes on Surgical Complications in Colorectal Surgery

Official title: Analysis of Mechanism on the Efficacy of Oral Antibiotic Prophylaxis in Elective Colon and Rectal Surgery With Primary Anastomosis

Run by Uzsoki Hospital · NCT05779254 · Data updated 2026-05-14

This study is no longer in our active list. It may have stopped recruiting or finished. The details below are as of 2026-05-14 and are kept for reference. Check ClinicalTrials.gov for its current status, or see similar studies below.

This study is trying to see if changes in gut bacteria affect the risk of complications after colorectal surgery, especially for patients having a specific type of surgery.

More Anastomotic Leak trials

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment100 (estimated)
SponsorUzsoki Hospital
Academic / other
Locations3 sites (Budapest and 2 other locations)
Trial IDNCT05779254 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include adults scheduled for colorectal surgery with planned circular stapled anastomosis who are not allergic to antibiotics.

Probably not a fit

Patients who have received antibiotics within two weeks prior to the study or those with chronic immunosuppression may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study investigates the relationship between the microbiome and surgical complications, specifically focusing on anastomotic leaks in colorectal surgery. It examines how variations in gut bacteria may influence surgical outcomes, particularly in patients undergoing circular stapled anastomosis. The study will involve administering neomycin sulfate as part of the bowel preparation process and analyzing intraoperative specimens for bacterial diversity. By understanding these dynamics, the research aims to identify risk factors associated with anastomotic failure and improve surgical techniques.

Why it matters

Potential benefit: If successful, this study could lead to improved surgical outcomes and reduced rates of complications for patients undergoing colorectal surgery.

How similar studies have gone: While the specific approach of this study is novel, previous research has indicated that microbiome diversity can impact surgical outcomes, suggesting potential for success.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Circular stapled anastomosis
* Planned surgery with colo-colic anastomosis
* No passage disorder, as it is confirmed at the first medical examination
* Not allergic to antibiotics
* Can receive a bowel preparation
* No proximal excluded intestine, i.e., the bowel preparation may be successful (ileostomy)

Exclusion Criteria:

* treated with antibiotics within 2 weeks before randomisation
* allergic to any of the medicines used
* under 18 years of age
* have suffered from abdominal sepsis within 6 months prior to recruitment
* pregnancy or breastfeeding
* been treated with steroids
* any form of chronic immunosuppression

Where it's running

  • Uzsoki Hospital
    Budapest, Hungary
    Recruiting
  • University of Debrecen
    Debrecen, Hungary
    Not yet recruiting
  • Csolnoky Ferenc Kórház
    Veszprém, Hungary
    Not yet recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.